3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
14
Breast Neoplasms
12
Lung Neoplasms
10
Uterine Cervical Neoplasms
9
Neoplasms
8
Colonic Neoplasms
5
Hematopoietic and Lymphatic System Neoplasm
4
Prostatic Neoplasms
3
Papillomavirus Infections
3
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Patient Compliance
2
Carcinoma, Intraductal, Noninfiltrating
2
Tobacco Use
1
Smoking
1
Pyloric Stenosis, Hypertrophic
1
Psychological Well-Being
1
Overweight
1
Obesity
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Blood Specimen Collection
7
Pentoxifylline
4
Liver Transplantation
4
Magnetic Resonance Spectroscopy
3
Tocopherols
2
Low-Level Light Therapy
2
High-Energy Shock Waves
2
tremelimumab
1
sonidegib
1
maltodextrin
1
epigallocatechin gallate
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
apixaban
1
alpha-Tocopherol
1
Vitamin E
1
Vitamin D
1
User-Centered Design
1
Tenofovir
1
Surveys and Questionnaires
1
Sunitinib
1
Standard of Care
1
Spermine Synthase
1
Specimen Handling
1
Sorafenib
1
Sonazoid
1
Sodium Chloride
1
Sampling Studies
1
Restraint, Physical
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Fibrosis
×
Patient Navigation
×
Clear all
NCT06458998
2026-02-23
GTI
University of Pittsburgh
Phase NA
Enrolling by invitation
30,300 enrolled